Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20230933Phase 3Completed
A Phase 3 trial of HR19006 in None, sponsored by Fujian Shengdi Pharmaceuticals. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20230933.